Budesonide Capsules Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Types (1mg, 2mg, 3mg); Application (Crohn's Disease, Collagenous Colitis, Autoimmune Hepatitis)

Report Code: TIPRE00021682 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Budesonide is used to treat Crohn's disease, a situation where the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever, and other such diseases. It is a potent corticosteroid with low systemic bioavailability due to extended first-pass liver metabolism.

MARKET DYNAMICS

Increasing cases of crohn's disease, collagenous colitis, and autoimmune hepatitis, along with the people awareness about the treatment are the major factors for market growth. For instance, in 2015, an estimated 1.3% of US adults, approximately 3 million people, reported being diagnosed with IBD (either Crohn's disease or ulcerative colitis). This was a large increase from 1999 (0.9% or 2 million adults).

MARKET SCOPE

The "Budesonide Capsules Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Budesonide capsules market with detailed market segmentation by type and application. The budesonide capsules market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Budesonide capsules market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The budesonide capsules market is segmented on the basis of type and application. Based on type, the market is segmented as complicated as 1mg, 2mg, and 3mg. Based on application, the market is segmented as crohn's disease, collagenous colitis, and autoimmune hepatitis.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Budesonide capsules market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Budesonide capsules market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Budesonide capsules market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Budesonide capsules market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Budesonide capsules market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Budesonide capsules market are anticipated to have lucrative growth opportunities in the future with the rising demand for Budesonide capsules in the global market. Below mentioned is the list of few companies engaged in the budesonide capsules market.

The report also includes the profiles of key players in Budesonide capsules market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and type and application offered, financial information of last 3 years, key development in past five years.

  •   PERRIGO
  •   MYLAN
  •   TILLOTTS PHARMA
  •   TEVA PHARMACEUTICAL
  •   ZYDUS PHARMACEUTICALS
  •   AMNEAL
  •   MAYNE PHARMA
  •   SCIECURE PHARMA
  •   ORION CORPORATION
  •   COSMO PHARMACEUTICALS

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Budesonide Capsules Market - By Types
1.3.2 Budesonide Capsules Market - By Application
1.3.3 Budesonide Capsules Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BUDESONIDE CAPSULES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BUDESONIDE CAPSULES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BUDESONIDE CAPSULES MARKET - GLOBAL MARKET ANALYSIS
6.1. BUDESONIDE CAPSULES - GLOBAL MARKET OVERVIEW
6.2. BUDESONIDE CAPSULES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BUDESONIDE CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - TYPES
7.1. OVERVIEW
7.2. TYPES MARKET FORECASTS AND ANALYSIS
7.3. 1MG
7.3.1. Overview
7.3.2. 1mg Market Forecast and Analysis
7.4. 2MG
7.4.1. Overview
7.4.2. 2mg Market Forecast and Analysis
7.5. 3MG
7.5.1. Overview
7.5.2. 3mg Market Forecast and Analysis
8. BUDESONIDE CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CROHN'S DISEASE
8.3.1. Overview
8.3.2. Crohn's Disease Market Forecast and Analysis
8.4. COLLAGENOUS COLITIS
8.4.1. Overview
8.4.2. Collagenous Colitis Market Forecast and Analysis
8.5. AUTOIMMUNE HEPATITIS
8.5.1. Overview
8.5.2. Autoimmune Hepatitis Market Forecast and Analysis
9. BUDESONIDE CAPSULES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Budesonide Capsules Market Overview
9.1.2 North America Budesonide Capsules Market Forecasts and Analysis
9.1.3 North America Budesonide Capsules Market Forecasts and Analysis - By Types
9.1.4 North America Budesonide Capsules Market Forecasts and Analysis - By Application
9.1.5 North America Budesonide Capsules Market Forecasts and Analysis - By Countries
9.1.5.1 United States Budesonide Capsules Market
9.1.5.1.1 United States Budesonide Capsules Market by Types
9.1.5.1.2 United States Budesonide Capsules Market by Application
9.1.5.2 Canada Budesonide Capsules Market
9.1.5.2.1 Canada Budesonide Capsules Market by Types
9.1.5.2.2 Canada Budesonide Capsules Market by Application
9.1.5.3 Mexico Budesonide Capsules Market
9.1.5.3.1 Mexico Budesonide Capsules Market by Types
9.1.5.3.2 Mexico Budesonide Capsules Market by Application
9.2. EUROPE
9.2.1 Europe Budesonide Capsules Market Overview
9.2.2 Europe Budesonide Capsules Market Forecasts and Analysis
9.2.3 Europe Budesonide Capsules Market Forecasts and Analysis - By Types
9.2.4 Europe Budesonide Capsules Market Forecasts and Analysis - By Application
9.2.5 Europe Budesonide Capsules Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Budesonide Capsules Market
9.2.5.1.1 Germany Budesonide Capsules Market by Types
9.2.5.1.2 Germany Budesonide Capsules Market by Application
9.2.5.2 France Budesonide Capsules Market
9.2.5.2.1 France Budesonide Capsules Market by Types
9.2.5.2.2 France Budesonide Capsules Market by Application
9.2.5.3 Italy Budesonide Capsules Market
9.2.5.3.1 Italy Budesonide Capsules Market by Types
9.2.5.3.2 Italy Budesonide Capsules Market by Application
9.2.5.4 Spain Budesonide Capsules Market
9.2.5.4.1 Spain Budesonide Capsules Market by Types
9.2.5.4.2 Spain Budesonide Capsules Market by Application
9.2.5.5 United Kingdom Budesonide Capsules Market
9.2.5.5.1 United Kingdom Budesonide Capsules Market by Types
9.2.5.5.2 United Kingdom Budesonide Capsules Market by Application
9.2.5.6 Rest of Europe Budesonide Capsules Market
9.2.5.6.1 Rest of Europe Budesonide Capsules Market by Types
9.2.5.6.2 Rest of Europe Budesonide Capsules Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Budesonide Capsules Market Overview
9.3.2 Asia-Pacific Budesonide Capsules Market Forecasts and Analysis
9.3.3 Asia-Pacific Budesonide Capsules Market Forecasts and Analysis - By Types
9.3.4 Asia-Pacific Budesonide Capsules Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Budesonide Capsules Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Budesonide Capsules Market
9.3.5.1.1 Australia Budesonide Capsules Market by Types
9.3.5.1.2 Australia Budesonide Capsules Market by Application
9.3.5.2 China Budesonide Capsules Market
9.3.5.2.1 China Budesonide Capsules Market by Types
9.3.5.2.2 China Budesonide Capsules Market by Application
9.3.5.3 India Budesonide Capsules Market
9.3.5.3.1 India Budesonide Capsules Market by Types
9.3.5.3.2 India Budesonide Capsules Market by Application
9.3.5.4 Japan Budesonide Capsules Market
9.3.5.4.1 Japan Budesonide Capsules Market by Types
9.3.5.4.2 Japan Budesonide Capsules Market by Application
9.3.5.5 South Korea Budesonide Capsules Market
9.3.5.5.1 South Korea Budesonide Capsules Market by Types
9.3.5.5.2 South Korea Budesonide Capsules Market by Application
9.3.5.6 Rest of Asia-Pacific Budesonide Capsules Market
9.3.5.6.1 Rest of Asia-Pacific Budesonide Capsules Market by Types
9.3.5.6.2 Rest of Asia-Pacific Budesonide Capsules Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Budesonide Capsules Market Overview
9.4.2 Middle East and Africa Budesonide Capsules Market Forecasts and Analysis
9.4.3 Middle East and Africa Budesonide Capsules Market Forecasts and Analysis - By Types
9.4.4 Middle East and Africa Budesonide Capsules Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Budesonide Capsules Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Budesonide Capsules Market
9.4.5.1.1 South Africa Budesonide Capsules Market by Types
9.4.5.1.2 South Africa Budesonide Capsules Market by Application
9.4.5.2 Saudi Arabia Budesonide Capsules Market
9.4.5.2.1 Saudi Arabia Budesonide Capsules Market by Types
9.4.5.2.2 Saudi Arabia Budesonide Capsules Market by Application
9.4.5.3 U.A.E Budesonide Capsules Market
9.4.5.3.1 U.A.E Budesonide Capsules Market by Types
9.4.5.3.2 U.A.E Budesonide Capsules Market by Application
9.4.5.4 Rest of Middle East and Africa Budesonide Capsules Market
9.4.5.4.1 Rest of Middle East and Africa Budesonide Capsules Market by Types
9.4.5.4.2 Rest of Middle East and Africa Budesonide Capsules Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Budesonide Capsules Market Overview
9.5.2 South and Central America Budesonide Capsules Market Forecasts and Analysis
9.5.3 South and Central America Budesonide Capsules Market Forecasts and Analysis - By Types
9.5.4 South and Central America Budesonide Capsules Market Forecasts and Analysis - By Application
9.5.5 South and Central America Budesonide Capsules Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Budesonide Capsules Market
9.5.5.1.1 Brazil Budesonide Capsules Market by Types
9.5.5.1.2 Brazil Budesonide Capsules Market by Application
9.5.5.2 Argentina Budesonide Capsules Market
9.5.5.2.1 Argentina Budesonide Capsules Market by Types
9.5.5.2.2 Argentina Budesonide Capsules Market by Application
9.5.5.3 Rest of South and Central America Budesonide Capsules Market
9.5.5.3.1 Rest of South and Central America Budesonide Capsules Market by Types
9.5.5.3.2 Rest of South and Central America Budesonide Capsules Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BUDESONIDE CAPSULES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BUDESONIDE CAPSULES MARKET, KEY COMPANY PROFILES
12.1. PERRIGO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MYLAN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TILLOTTS PHARMA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TEVA PHARMACEUTICAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ZYDUS PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AMNEAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MAYNE PHARMA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SCIECURE PHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ORION CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. COSMO PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. PERRIGO
2. MYLAN
3. TILLOTTS PHARMA
4. TEVA PHARMACEUTICAL
5. ZYDUS PHARMACEUTICALS
6. AMNEAL
7. MAYNE PHARMA
8. SCIECURE PHARMA
9. ORION CORPORATION
10. COSMO PHARMACEUTICALS
11. SUN PHARMA
12. ASTRAZENECA
13. AMNEAL BIOSCIENCES
14. NATCO PHARMA
15. NEPHRON PHARMACEUTICAL
TIPRE00021682
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking